Question 1

What is the catalog number for WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22)?

Accepted Answer

The catalog number for WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22) is 253419.

Question 2

What sizes are available for WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22)?

Accepted Answer

WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22) is available in the following size(s): 50 µL.

Question 3

Is WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22) in stock?

Accepted Answer

WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

WDFY2 (WD Repeat and FYVE Domain Containing 2, PROF, RP11-147H23.1, WDF2, ZFYVE22)

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Bcl-6 (Follicular Lymphoma Marker) (BCL6/1527), Biotin conjugate, 0.1mg/mL

RAD51 (Prognostic and Response to Chemotherapy Marker) (RAD51/2765), CF568 conjugate, 0.1mg/mL

CD79a (B-Cell Marker) (rIGA/764), CF640R conjugate, 0.1mg/mL

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), 0.2mg/mL

CD45RO (UCHL1 + T200/797), Biotin conjugate, 0.1mg/mL

Cdc20 (AR12), CF647 conjugate, 0.1mg/mL